Powder strength distributions for understanding de-agglomeration of lactose powders

Shyamal Chandra Das, Srinivas Ravindra Babu Behara, Jurgen Bernd Bulitta, David Alexander Vodden Morton, Ian Clair Larson, Peter James Stewart

Research output: Contribution to journalArticleResearchpeer-review

19 Citations (Scopus)

Abstract

Both active pharmaceutical ingredients (API) and ternary components such as lactose, commonly used in dry powder inhaler (DPI) formulations, are micron-sized and form cohesive matrices due to interparticulate interactions. In powder mixtures, these cohesive structures may be complex depending on the propensity of the cohesive-adhesive interactions of the materials. The de-agglomeration and aerosolization of these cohesive matrices are essential for effective delivery to the lower respiratory tract, the principal target of most respiratory drug delivery treatment. Although the target particle size of de-agglomerated powders is determined by the utilization purpose, it should be less than 5 I?m for deposition in the lower respiratory tract. The factors influencing the complex de-agglomeration process have been a focus of research for better formulation design.
Original languageEnglish
Pages (from-to)2926 - 2935
Number of pages10
JournalPharmaceutical Research
Volume29
Issue number10
DOIs
Publication statusPublished - 2012

Cite this

Das, Shyamal Chandra ; Behara, Srinivas Ravindra Babu ; Bulitta, Jurgen Bernd ; Morton, David Alexander Vodden ; Larson, Ian Clair ; Stewart, Peter James. / Powder strength distributions for understanding de-agglomeration of lactose powders. In: Pharmaceutical Research. 2012 ; Vol. 29, No. 10. pp. 2926 - 2935.
@article{a13b29fa32964544a607d4423a52a86c,
title = "Powder strength distributions for understanding de-agglomeration of lactose powders",
abstract = "Both active pharmaceutical ingredients (API) and ternary components such as lactose, commonly used in dry powder inhaler (DPI) formulations, are micron-sized and form cohesive matrices due to interparticulate interactions. In powder mixtures, these cohesive structures may be complex depending on the propensity of the cohesive-adhesive interactions of the materials. The de-agglomeration and aerosolization of these cohesive matrices are essential for effective delivery to the lower respiratory tract, the principal target of most respiratory drug delivery treatment. Although the target particle size of de-agglomerated powders is determined by the utilization purpose, it should be less than 5 I?m for deposition in the lower respiratory tract. The factors influencing the complex de-agglomeration process have been a focus of research for better formulation design.",
author = "Das, {Shyamal Chandra} and Behara, {Srinivas Ravindra Babu} and Bulitta, {Jurgen Bernd} and Morton, {David Alexander Vodden} and Larson, {Ian Clair} and Stewart, {Peter James}",
year = "2012",
doi = "10.1007/s11095-012-0799-0",
language = "English",
volume = "29",
pages = "2926 -- 2935",
journal = "Pharmaceutical Research",
issn = "0724-8741",
publisher = "American Association of Pharmaceutical Scientists (AAPS)",
number = "10",

}

Powder strength distributions for understanding de-agglomeration of lactose powders. / Das, Shyamal Chandra; Behara, Srinivas Ravindra Babu; Bulitta, Jurgen Bernd; Morton, David Alexander Vodden; Larson, Ian Clair; Stewart, Peter James.

In: Pharmaceutical Research, Vol. 29, No. 10, 2012, p. 2926 - 2935.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Powder strength distributions for understanding de-agglomeration of lactose powders

AU - Das, Shyamal Chandra

AU - Behara, Srinivas Ravindra Babu

AU - Bulitta, Jurgen Bernd

AU - Morton, David Alexander Vodden

AU - Larson, Ian Clair

AU - Stewart, Peter James

PY - 2012

Y1 - 2012

N2 - Both active pharmaceutical ingredients (API) and ternary components such as lactose, commonly used in dry powder inhaler (DPI) formulations, are micron-sized and form cohesive matrices due to interparticulate interactions. In powder mixtures, these cohesive structures may be complex depending on the propensity of the cohesive-adhesive interactions of the materials. The de-agglomeration and aerosolization of these cohesive matrices are essential for effective delivery to the lower respiratory tract, the principal target of most respiratory drug delivery treatment. Although the target particle size of de-agglomerated powders is determined by the utilization purpose, it should be less than 5 I?m for deposition in the lower respiratory tract. The factors influencing the complex de-agglomeration process have been a focus of research for better formulation design.

AB - Both active pharmaceutical ingredients (API) and ternary components such as lactose, commonly used in dry powder inhaler (DPI) formulations, are micron-sized and form cohesive matrices due to interparticulate interactions. In powder mixtures, these cohesive structures may be complex depending on the propensity of the cohesive-adhesive interactions of the materials. The de-agglomeration and aerosolization of these cohesive matrices are essential for effective delivery to the lower respiratory tract, the principal target of most respiratory drug delivery treatment. Although the target particle size of de-agglomerated powders is determined by the utilization purpose, it should be less than 5 I?m for deposition in the lower respiratory tract. The factors influencing the complex de-agglomeration process have been a focus of research for better formulation design.

UR - http://link.springer.com/content/pdf/10.1007%2Fs11095-012-0799-0

U2 - 10.1007/s11095-012-0799-0

DO - 10.1007/s11095-012-0799-0

M3 - Article

VL - 29

SP - 2926

EP - 2935

JO - Pharmaceutical Research

JF - Pharmaceutical Research

SN - 0724-8741

IS - 10

ER -